Integer Holdings Corporation (NYSE:ITGR) Given Average Rating of "Buy" by Analysts

Integer Holdings Corporation (NYSE:ITGR - Get Free Report) has received a consensus recommendation of "Buy" from the nine research firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $145.00.

A number of research firms recently issued reports on ITGR. Benchmark lowered their price objective on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday, April 25th. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a "buy" rating in a research report on Friday, April 25th. KeyCorp lowered their price objective on shares of Integer from $154.00 to $145.00 and set an "overweight" rating for the company in a research report on Monday, April 21st. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research report on Monday, May 19th. Finally, Raymond James Financial upped their price objective on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research report on Friday, April 25th.

Integer Stock Performance

Shares of Integer stock opened at $119.61 on Tuesday. The company has a 50 day moving average of $119.91 and a 200-day moving average of $124.82. Integer has a 1-year low of $104.93 and a 1-year high of $146.36. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78. The company has a market cap of $4.17 billion, a PE ratio of 56.69, a price-to-earnings-growth ratio of 1.03 and a beta of 0.98.

Integer (NYSE:ITGR - Get Free Report) last issued its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The company had revenue of $437.39 million during the quarter, compared to the consensus estimate of $428.51 million. During the same quarter in the prior year, the firm posted $1.14 EPS. The firm's quarterly revenue was up 7.3% on a year-over-year basis. As a group, equities research analysts forecast that Integer will post 6.01 earnings per share for the current fiscal year.

Insider Transactions at Integer

In other news, Director Donald J. Spence sold 14,739 shares of the stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total transaction of $1,774,280.82. Following the completion of the sale, the director directly owned 18,781 shares in the company, valued at $2,260,856.78. This represents a 43.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the sale, the director owned 22,170 shares of the company's stock, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 over the last three months. 2.16% of the stock is owned by company insiders.

Institutional Investors Weigh In On Integer

A number of large investors have recently bought and sold shares of the stock. Lee Danner & Bass Inc. acquired a new position in shares of Integer during the fourth quarter valued at about $27,000. AdvisorNet Financial Inc acquired a new position in shares of Integer during the first quarter valued at about $28,000. Opal Wealth Advisors LLC acquired a new position in shares of Integer during the first quarter valued at about $28,000. Bessemer Group Inc. grew its holdings in shares of Integer by 73.1% during the first quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after buying an additional 125 shares during the last quarter. Finally, SVB Wealth LLC acquired a new position in shares of Integer during the first quarter valued at about $35,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.